In order to help facilitate an accurate genetic diagnosis, MSTO1 should be included in targeted next-generation-based neuromuscular, mitochondrial and ataxia-related panels, where MSTO1 is currently not included. This evidence concerns the gene MSTO1 and Ataxia.